Tucson / Rockville / Washington / DC / Phoenix / /
Company
Johnson & Johnson / Eli Lilly and Company / AstraZeneca Pharmaceuticals LP / Bristol-Myers Squibb Company / Novartis Pharmaceuticals Corporation / C-Path / US Inc. / GlaxoSmithKline / Pfizer Inc. / F. Hoffmann-La Roche Ltd / Genentech Inc. / CHDI Foundation Inc / CAMD / /
Continent
Europe / /
Country
United States / /
Currency
USD / / /
Event
M&A / /
Facility
National Institute of Neurological Disorders / National Institute / Forest Research Institute / Critical Path Institute / About Critical Path Institute / /
IndustryTerm
therapies for neurodegenerative diseases / pharmaceutical / biopharmaceutical drug development / pharmaceutical members / /
National Institute on Aging / Brookings Institution / Forest Research Institute / Critical Path Institute / National Health Council / National Institute of Neurological Disorders and Stroke / C-Path’s mission / European Medicines Agency / Coalition Against Major Diseases / U.S. Food and Drug Administration / Alzheimer's Association / Alliance for Aging Research / CDISC / Alzheimer's Foundation of America / Engelberg Center for Health Care Reform / /
Person
Joshua Sharfstein / Raymond Woosley / Marc Cantillon / Mark McClellan / Maria Isaac / Frank Casty / Care Reform / Rick Myers / Critical Path Initiative / / /
Position
advisors / Co-Director / Scientific Administrator / Scientific Advice / Deputy Commissioner / VP Technical Evaluations / director / President and CEO / Commissioner / Major / /
Embargoed for 12:01 a.m. Friday, June 11, 2010 Contact: